Geographic Atrophy Due to Age-related Macular Degeneration

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2023-08-04
FDA Approved: IZERVAY — Original Application (Astellas Pharma US, Inc.)
FDA approved IZERVAY (avacincaptad pegol) from Astellas for geographic atrophy due to age-related macular degeneration.